72 related articles for article (PubMed ID: 8675196)
21. Autocrine release of TGF-beta by portal fibroblasts regulates cell growth.
Wells RG; Kruglov E; Dranoff JA
FEBS Lett; 2004 Feb; 559(1-3):107-10. PubMed ID: 14960316
[TBL] [Abstract][Full Text] [Related]
22. Cirrhosis--can we reverse hepatic fibrosis?
Tangkijvanich P; Yee HF
Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
[TBL] [Abstract][Full Text] [Related]
23. Prevention of liver cirrhosis in rats by curcumin.
Bruck R; Ashkenazi M; Weiss S; Goldiner I; Shapiro H; Aeed H; Genina O; Helpern Z; Pines M
Liver Int; 2007 Apr; 27(3):373-83. PubMed ID: 17355460
[TBL] [Abstract][Full Text] [Related]
24. Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver.
Kamath PS; Carpenter HA; Lloyd RV; McKusick MA; Steers JL; Nagorney DM; Miller VM
Liver Transpl; 2000 Sep; 6(5):596-602. PubMed ID: 10980059
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
[TBL] [Abstract][Full Text] [Related]
26. [The mechanism of liver fibrosis become clearer. Drugs against the fibrotic process coming].
Hultcrantz R
Lakartidningen; 2006 May 17-30; 103(20):1588-9. PubMed ID: 16800083
[No Abstract] [Full Text] [Related]
27. [Interferon-alpha and liver fibrosis in patients with chronic damage due to hepatitis C virus].
Gonzalez-Huezo MS; Gallegos-Orozco JF
Rev Gastroenterol Mex; 2003; 68(3):239-44. PubMed ID: 14702938
[TBL] [Abstract][Full Text] [Related]
28. Imbalance between expression of endothelin receptors A and B in terminal liver cirrhosis due to hepatitis C viral infection: immunohistochemical study of autopsy cases.
Kitamura Y; Hayashi K
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e451-6. PubMed ID: 17565586
[TBL] [Abstract][Full Text] [Related]
29. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
Svegliati-Baroni G; De Minicis S; Marzioni M
Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
[TBL] [Abstract][Full Text] [Related]
30. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
Cho SW; Cheong JY
Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
[TBL] [Abstract][Full Text] [Related]
31. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
32. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC;
Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997
[TBL] [Abstract][Full Text] [Related]
33. Liver extracellular matrix in health and disease.
Bedossa P; Paradis V
J Pathol; 2003 Jul; 200(4):504-15. PubMed ID: 12845618
[TBL] [Abstract][Full Text] [Related]
34. [Endothelin, a vascular hormone].
de Groote P; Tison E; Millaire A; Decoulx E; Ducloux G
Ann Med Interne (Paris); 1992; 143(7):448-54. PubMed ID: 1300866
[No Abstract] [Full Text] [Related]
35. Endothelin: progress in pharmacology and physiology.
Haynes WG; Davenport AP; Webb DJ
Trends Pharmacol Sci; 1993 Jun; 14(6):225-8. PubMed ID: 8372400
[No Abstract] [Full Text] [Related]
36. [Endothelin-1 and liver disease].
Regev A; Shyper-Kravitz M; Theodor E
Harefuah; 1995 Jun; 128(11):703-7. PubMed ID: 7557670
[No Abstract] [Full Text] [Related]
37. Aetiology of hepatic cirrhosis.
Banerjea JC
J Indian Med Assoc; 1968 Sep; 51(5):253-5. PubMed ID: 5705307
[No Abstract] [Full Text] [Related]
38. Physiology and pharmacology of endothelins.
Masaki T; Yanagisawa M; Goto K
Med Res Rev; 1992 Jul; 12(4):391-421. PubMed ID: 1528080
[No Abstract] [Full Text] [Related]
39. Contrast-enhanced ultrasound to diagnose small liver cancer in cirrhosis: friend or foe?
Vezali E; Colombo M
Gastroenterology; 2010 Dec; 139(6):2209-12. PubMed ID: 20970445
[No Abstract] [Full Text] [Related]
40. TGFβ signaling: a friend or a foe to hepatic fibrosis and tumorigenesis.
Kopanja D; Raychaudhuri P
Ann Transl Med; 2016 Mar; 4(6):122. PubMed ID: 27127775
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
